Cure My Disease

Don't miss your cure!

 Log in / Sign up

Chin filler retreatment safety under study

NCT ID NCT07566286

Recruiting now Symptom relief Sponsor: Galderma R&D Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 4 times

Summary

This study looks at the safety of using Restylane Lyft with Lidocaine, a hyaluronic acid gel, for a second treatment to improve the chin profile. About 100 adults aged 22 and older will receive the retreatment. The main goal is to track any side effects related to the gel or injection procedure three months after retreatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Restylane Lyft with Lidocaine (hyaluronic acid gel)
What this could lead to
If successful, this could confirm that retreating the chin with Restylane Lyft is safe for improving chin shape.
What could go wrong
This is a small, early-stage safety study with no comparison group, so results may not apply to everyone. Risks include allergic reactions or injection-site issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHIN AUGMENTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHIN AUGMENTATION

Contacts and locations

Locations

  • Galderma Investigational Site # 7030

    RECRUITING

    Coral Gables, Florida, 33134, United States

  • Galderma Investigational Site # 7042

    RECRUITING

    Atlanta, Georgia, 30331, United States

  • Galderma Investigational Site # 7043

    NOT_YET_RECRUITING

    Bethesda, Maryland, 20852, United States

  • Galderma Investigational Site # 7118

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Galderma Investigational Site # 8662

    RECRUITING

    Spring, Texas, 77388, United States

  • Galderma Investigational Site # 8680

    RECRUITING

    Westport, Connecticut, 06880, United States

  • Galderma Investigational Site # 8682

    RECRUITING

    Coral Gables, Florida, 33134, United States

  • Galderma Investigational Site # 8774

    RECRUITING

    Boynton Beach, Florida, 33437, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.